-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
-
Summary
-
Elite Pharmaceuticals Inc /Nv/ quarterly Deferred Income Tax Assets, Net history and growth rate from Q1 2022 to Q3 2024.
- Elite Pharmaceuticals Inc /Nv/ Deferred Income Tax Assets, Net for the quarter ending September 30, 2024 was $20.8M, a 7.26% increase year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Growth (%)